Latest News

Merck Pushes Forward With Potential Deal for Seagen


Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year.

The Wall Street Journal that Merck was in talks to buy Seagen, which would beef up the pharmaceutical giant’s cancer-drug portfolio, but that no agreement was imminent. The talks have picked up pace and the two companies are scheduled to meet this week, some of the people said Thursday.

Insiders Are Flashing a Strong Buy Signal for These 2 Stocks

Previous article

China’s Tech Giants Lost Their Swagger and May Never Get It Back

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News